Results 141 to 150 of about 2,160 (157)

NKG2D (Natural Killer Group 2, Member D) ligand expression and ameloblastoma recurrence: a retrospective immunohistological pilot study. [PDF]

BMC Oral Health
Kim MS, Jeon S, Lee HJ, Ri HS, Cho AR, Park EJ, Yeo JS, Kim JH, Lee J.   +8 more
europepmc   +1 more source

Synergistic innate-adaptive immunity by NKG2D-specific CAR-macrophages drives durable remission in hepatocellular carcinoma. [PDF]

Mol Cancer
Zhao Z, Zheng W, He Y, Zhang H, Zhang L, Huo Y, Jiang J, Zhang C, Lyu H, Qin W, Liu C, Chang F, Shan L, Wang T, Song W.   +14 more
europepmc   +1 more source

23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation. [PDF]

Cancer Res Commun
Benjamin JS, Jarret A, Bharill S, Fontanillas P, 23andMe Research Team, Yadav S, Sen D, Ayupova D, Kellar D, Tilk S, Hom C, Bahrami Dizicheh Z, Chen IL, Diep AN, Shi S, Ivic N, Bonnans C, Owyang A, Sood P, Fuh G, Schmidt M, Gerrick KY, Koenig P, Poggio M.   +23 more
europepmc   +1 more source

A Conserved WW Domain-Like Motif Regulates Invariant Chain-Dependent Cell-Surface Transport of the NKG2D Ligand ULBP2

Molecular Immunology, 2015
Malignant cells expressing NKG2D ligands on their cell surface can be directly sensed and killed by NKG2D-bearing lymphocytes. To ensure this immune recognition, accumulating evidence suggests that NKG2D ligands are trafficed via alternative pathways to ...
Esther van Andel, Lars Andresen, Søren Skov   +2 more
exaly   +2 more sources

miR-17–5p/STAT3/H19: A Novel Regulatory Axis Tuning ULBP2 Expression in Young Breast Cancer Patients [PDF]

Pathology Research and Practice
BACKGROUND AND AIM: UL-16 binding protein 2 (ULBP2) is a highly altered ligand for the activating receptor, NKG2D in breast cancer (BC). However, the mechanism behind its de-regulation in BC patients remains to be explored.
Rana Ahmed Youness
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

B7-H3 Confers Resistance to Vγ9Vδ2 T Cell-Mediated Cytotoxicity in Human Colon Cancer Cells via the STAT3/ULBP2 Axis

Cancer Immunology, Immunotherapy, 2021
Zhang Guangbo, Tongguo Shi, Gu Yanzheng
exaly  

ULBP2 Is a Biomarker Related to Prognosis and Immunity in Colon Cancer

Molecular and Cellular Biochemistry, 2023
Dekui Zhang, Zhiping Wu
exaly  

Clinical Significance of the NKG2D Ligands, MICA/B and ULBP2 in Ovarian Cancer: High Expression of ULBP2 Is an Indicator of Poor Prognosis

Cancer Immunology, Immunotherapy, 2009
Ayako Suzuki, Noriomi Matsumura
exaly  

Divergence and Diversity of ULBP2 Genes in Rhesus and Cynomolgus Macaques

Immunogenetics, 2014
Hirofumi Akari, Tetsuro Matano, Akinori Kimura   +2 more
exaly  

The Utility of a High-Throughput Scanning Biosensor in the Detection of the Pancreatic Cancer Marker ULBP2

Biosensors and Bioelectronics, 2013
Chien Chou, Chao-Sung Lai, Yu Jau-song
exaly